Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Accutane, acne, acneiform, ACORN, adalimumab, adapalene, aimed, alopecia, Amnesteem, API, apportioned, areata, artificially, Avage, Avita, BBA, Benzaclin, Benzamycin, Biden, BMS, BPCA, Brexit, buy, calcineurin, carcinoma, category, cervical, CGI, chemotherapy, Circle, clindamycin, closure, cobolimab, colorectal, comorbidity, complaint, CPRA, deficient, delete, DGCL, dibutyl, Differin, dinitrochlorobenzene, diphencyprone, dismissed, dMMREC, draft, dry, Duac, duty, EGFRi, elongation, endometrial, enrichment, epidemic, epidemiology, epidermal, Erythema, erythromycin, ester, explained, fallopian, Festival, fiduciary, fluid, foot, group, hard, harder, Harmonisation, HARP, hereinafter, HHS, Humira, ill, illegitimate, imaging, implanted, impression, imsidolimab, incapacitated, infused, infusion, inherited, inhibitor, inquired, INSPIRE, instilled, instructed, inversa, isotretinoin, ix, journey, kinase, lab, Lanham, learning, liarozole, lowest, LP, MAA, magnitude, MEKi, mismatch, nationwide, neutrophilia, nondeductible, nonessential, Northern, NPS, occlusion, oncological, opine, opt, outpatient, ovarian, pandemic, Pandion, papulopustular, PARP, PdMMRT, peritoneal, physical, plaintiff, poly, polymerase, poverty, PPPASI, prejudice, pro, proscribed, qualitative, quantitative, RADIANCE, rash, rata, rectal, recurrent, registry, relaxing, remote, remotely, rentable, repair, rixolitinib, sanitation, sarcoma, sarecycline, scarring, sequelae, Seysara, shareholder, Shield, shutdown, solid, Southern, squaric, stoppage, strain, stronger, suppurativa, surgery, suspect, symptomatic, tailored, tazarotene, Tazorac, telework, tenant, thickened, thing, thoughtful, threat, thrive, tie, tofacitinib, top, tretinoin, Trex, trillion, tube, tumor, unchanged, unclear, unconstitutional, unexpired, unjust, unspecified, uphold, upregulated, urged, vast, vi, vigorously, vii, viii, Virtual, vitiligo, voluntarily, waste, Wateridge, workforce, workplace, Wuhan, Zejula
Removed:
AAAAI, AAD, acceleration, activation, acute, AE, AEs, aged, allergic, AMG, Amgen, analyzed, anrukinzumab, anti, array, asthma, AstraZeneca, atopy, AUD, BEAT, benralizumab, biotech, Bulletin, cancelable, capitalization, cellular, central, CHIP, chosen, Cinqair, collaborator, Composite, content, converted, creditable, cut, deductibility, Dermira, detachable, detection, differentiate, differentiated, distinctive, downstream, dysfunction, efficient, endothelial, eosinophilic, erosion, exacerbating, exceeded, excluding, exempt, Expiratory, fasenra, FceRI, formula, GDP, GILTI, graph, handful, Harmonization, helper, ICS, IgE, implicated, imposing, inadequately, inapplicable, incidence, ineligible, inhibited, Innate, intangible, internalized, intervened, intervention, invested, kickback, Kyoto, LABA, leader, lebrikizumab, LIBOR, Likewise, linked, MAD, mast, mediator, mepolizumab, MHRA, mononuclear, mucosal, mutated, mutation, neutropenia, noncurrent, notably, Nucala, Obama, obstructive, omalizumab, orchestrate, passed, PBMC, peanut, persistent, Pfizer, pharmacokinetic, plaque, post, preceded, presently, prioritized, prodromal, proved, provisional, pulmonary, purification, Reauthorization, reclassification, reclassified, refund, Regeneron, reinvestment, reliably, renew, repealing, repeatedly, requesting, rescue, reslizumab, resultant, revalued, Roche, SAB, SAD, secured, sera, SGR, soluble, stable, stimulation, structural, subset, supplemental, Sustainable, Taxation, terminal, territorial, Teva, tezepelumab, throughput, titer, tralokinumab, Unaudited, understood, unfold, University, upstream, version, warrant, Xolair
Filing tables
Filing exhibits
Related press release
ANAB similar filings
Filing view
External links
EXHIBIT 21.1
SUBSIDIARIES OF THE REGISTRANT
Name of Subsidiary | Jurisdiction of Incorporation or Organization | ||||
AnaptysBio Pty Ltd | Australia |